You just read:

Statement from FDA Commissioner Scott Gottlieb, M.D. on advancing the development of novel treatments for neurological conditions; part of broader effort on modernizing FDA's new drug review programs

News provided by

U.S. Food and Drug Administration

Feb 15, 2018, 09:54 EST